Close Menu

NEW YORK – Natera reported after the close of the market on Wednesday that its fourth quarter 2019 revenues grew 24 percent year over year, while full-year revenues climbed 17 percent.

2019 "was clearly a transformational year for us across all focus areas," said Steve Chapman, the firm's CEO, on a conference call to discuss the financial results. "We delivered financial results above the top of our previous guidance."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.